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evidence stemming from these experiments suggests Medicaid has positive effects on access to care, health, and financial security. [8] [9] [10] [11] [12] [13] [14] For example, Medicaid expansion under the ACA led to an 8.2 percentage point improvement in insurance coverage, 5 8 and a decrease in unpaid medical bills of $3.4 billion over 2 years. 10 Although the population-level effects of state Medicaid expansions (i.e, average treatment effects) are well documented, less is known about Medicaid's direct impact among people who gain
Medicaid after a period of uninsurance (i.e, average treatment effect on the treated). The Oregon Health Insurance Experiment (OHIE), the most rigorous study to date to examine the impact of gaining
Medicaid at the individual level, found that uninsured individuals who gained Medicaid in Oregon state had significantly lower levels of depression and out-of-pocket spending and higher levels of prescription medication use than individuals who were not enrolled in Medicaid. [16] [17] [18] No other contemporary studies have followed individuals who gain Medicaid after a period of uninsurance. Such studies would be helpful to build on the findings of the OHIE and may shed light on whether identified associations are consistent across time, region, and race/ethnicity. These data are critical because they can inform ongoing policy debates regarding the design and funding of Medicaid, as well as efforts to improve racial and ethnic disparities in care. 12, [19] [20] [21] [22] We used a nationally representative panel survey to examine the impact of Medicaid enrollment on disparities in health care costs, access to care, and general health measures among previously uninsured Americans who transitioned onto Medicaid and stratified our analyses by race/ethnicity. Based on findings from the OHIE and populationlevel studies, we hypothesized that Medicaid enrollment would be associated with lower out-of-pocket costs, higher levels of prescription medication use and usual sources of care, and improvements in mental health.
| ME THODS

| Data and study population
We costs, utilization, and access, and self-reported health data. Medical
Expenditure Panel Survey has an overlapping panel design that surveys each respondent five times over a period of 2 years. Therefore, in any given year, half the sample is in their first year and half in their second year. To create our analytic sample, we restricted analyses to respondents who had 2 years of data, were between the ages of 19
and 64 (inclusive) in their first year of MEPS, who were not pregnant in either year, and whose family income was ≤400 percent of the federal poverty level in each year. We excluded pregnant individuals because pregnancy is a categorical eligibility for Medicaid and because patterns of health care in pregnancy are substantively different than for other health circumstances.
Our sample consisted of two groups: (a) those who remained uninsured throughout the 2-year study period and (b) those who gained
Medicaid after a period of uninsurance. We defined the latter population as respondents who were uninsured for at least 6 months within their first 9 months in MEPS (Period 1) and had at least 6 months of Medicaid coverage for the remaining 15 months (Period 2). We chose to set our cut-point at 9 months because nearly all individuals who gained Medicaid in our sample would have completed two rounds of surveys while uninsured prior to the fourth quarter of their first year in MEPS, and because this definition is similar to other evaluations of low-income populations who gain Medicaid. 23 To ensure all outcomes derived from round 2 of MEPS occurred in the first 9 months, we excluded individuals who did not complete round 2 by September of their first year in MEPS. Additionally, in sensitivity analyses, we vary each group definition to test the robustness of our results.
| Outcome measures
Health care costs, health care utilization, and self-reported general and mental health were obtained in each of the five MEPS survey rounds, but due to how the sample was created, we did not include values from round 3. We used values from rounds 1 and 2 during Period 1 and rounds 4 and 5 during Period 2 to ensure similar followup time across each period and to allow for a brief washout period between uninsurance and Medicaid enrollment. Access measures and psychological distress were only reported in rounds 2 and 4.
| Health care costs
We examined total health care costs and total out-of-pocket costs for individuals in Period 1 and Period 2, as well as total and out-ofpocket prescription drug costs. Each cost measure was adjusted to 2014 dollars using the Medical Component of the Consumer Price Index. 24 For inpatient, outpatient, and emergency department (ED) visits and prescription drug costs, MEPS collects data from the participating individual and their medical providers. 
| Health care utilization
We estimated having any ED visit, total number of ED visits per person, any inpatient visit, total number of inpatient visits per person, any prescription drug fill, and total number of prescription drug fills per person. These were obtained through medical provider records.
| Health care access
Several health care access measures were assessed, including a usual source of care, foregone medical care (i.e, "unable to get medical care, tests, or treatments a respondent or a doctor believed to be necessary"), delayed medical care (i.e, "delayed medical care, tests, or treatments a respondent or a doctor believed to be necessary"), or unable to get necessary prescription drugs (i.e, "unable to obtain prescription medicines a respondent or a doctor believed to be necessary"). Each of these outcomes was asked in rounds 2 and 4 and refers to the preceding 12 months. Chronic conditions (mean)
| Health outcomes
a Each participant was enrolled in the study for 2 y.
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In addition to our primary multivariable regression specifications, we ran a series of sensitivity analyses to examine the robustness of our results. First, we compared linear trends for costs, utilization, and self-reported health outcomes in Period 1 among individuals who gained Medicaid and those who remained uninsured. We did not assess Period 1 trends for access measures because data for these outcomes were only collected once during Period 1. Second, to ensure those who gained Medicaid and those who remained uninsured were well matched, we re estimated our difference-in-differences regressions using entropy balancing, an approach that directly reweights the control group to match the means (or other moments) of the treatment group. [28] [29] [30] We estimated two models using entropy balancing, first weighting with the covariates used in our baseline approach and second, weighting with round 1 and 2 values of the outcomes, using costs when the outcomes were not measured more than once in a period. In both cases, we used the resulting weights to estimate difference-in-differences regressions similar to our baseline analyses. Third, for cost variables, we re-estimated the models using a two-part model. [31] [32] [33] Finally, we made a variety of modifications to our definitions of both the Medicaid gainer population and the control group, in each case varying the number of months they were either uninsured or had Medicaid coverage.
| RE SULTS
Our sample included 10 747 individuals, including 963 Medicaid gainers and 9784 individuals who remained uninsured in both years of their participation in MEPS. As illustrated in Table 1 , those who gained Medicaid were more likely to be female, White, non-Hispanic, Black, non-Hispanic, below 100 percent of the federal poverty level, from the Midwest or Northeast, and more likely to be in the first cohort after ACA Medicaid expansion (i.e, their first year of MEPS participation was 2013).
| Health care costs
Next, we examined how each outcome changed from Period 1 to Period 2 among the entire sample. As indicated in Table 2 , both populations experienced significant increases in total costs-an increase of over $1700 for Medicaid gainers compared to an increase of just over $100 for those remaining uninsured. Both populations also experienced significant increases in total prescription drug costs-a $621 increase for those gaining Medicaid and a $48 increase for those remaining uninsured. While those remaining uninsured saw small increases in out-of-pocket costs, those gaining Medicaid experienced decreases in both total out-of-pocket costs and total prescription drug out-of-pocket costs (decreases of $219 and $142, respectively).
Among Medicaid gainers, White, non-Hispanic and Hispanic individuals experienced significant increases in total costs, whereas total costs among Black, non-Hispanic individuals did not increase significantly (Table 3) . Increases in total prescription drug costs were statistically significant across racial/ethnic groups.
| Health care utilization
We found no significant changes in ED and inpatient visits among individuals who gained Medicaid compared to those who remained uninsured (Table 2) . Those gaining Medicaid saw a significant 10.7
percentage point increase in having any prescription drug fills, while those remaining uninsured saw a modest, but statistically significant, decrease of 1.6 percentage points. However, both experienced significant increases in total number of prescription drug fills-an increase of over six fills for Medicaid gainers and a more modest increase of 0.8 fills for those remaining uninsured.
Decreasing levels of any drug fill and increasing number of total drug fills among individuals who remain uninsured may be related to increasing resource use among a concentrated sample of uninsured individuals over time. 34 Any prescription drug fills increased significantly among Black, non-Hispanic and Hispanic individuals who gained Medicaid, but not White, non-Hispanic individuals (Table 3) . However, total prescription drug fills increased across each racial/ethnic group, with the largest gains among White, non-Hispanic individuals who gained Medicaid coverage.
| Health care access
We also observed varying changes in access to care (Table 2) Usual source of care increased significantly among all racial/ethnic groups of Medicaid gainers, but the gains were smallest for Black, non-Hispanic individuals (Table 3 ). Inability to get necessary care decreased to a similar degree across racial/ethnic groups. Only White, non-Hispanic individuals reported significant decreases in delayed care due to costs and inability to get necessary prescriptions.
| Health outcomes
Individuals who gained Medicaid and those remaining uninsured both reported just under a 2.5 percentage point decrease in the probability of reporting fair or poor health, although this was only statistically significant for those remaining uninsured (Table 2) . Fair or poor mental health did not change significantly in either group.
However, those gaining Medicaid reported a significant 4.3 percentage point decrease in severe psychological distress, while those remaining uninsured reported a small and not statistically significant decrease.
Changes in health outcomes were not significant across racial/ ethnic groups gaining Medicaid, with the exception of severe psychological distress among Hispanics, which declined by 5.9 percentage points (Table 3) .
| Difference-in-differences estimates
In addition to examining changes in mean values of each outcome across Medicaid gainers and persistently uninsured individuals, we also obtained adjusted difference-in-differences estimates. We found no significant differences in changes in ED or inpatient utilization patterns between those gaining Medicaid and those remaining uninsured ( Finally, we found modest changes in health outcomes (Table 4) .
We did not find statistically significant differences in changes in selfreported fair/poor general or mental health. However, there was a 
| Sensitivity analyses
In our first sensitivity analysis, we examined linear trends in Period 1 using multivariable linear regression models. We found that trends were generally similar for individuals who gained Medicaid and those that remained uninsured. Statistically significant, though quantitatively modest, differences in linear trends during Period 1 were identified for three measures: total costs, any prescription drug fill, and total prescription drug fills (Table S1 ). Total cost and total prescription fill differences in Period 1 were <25 percent of our difference-in-differences estimate. Therefore, differences in Period 1 are unlikely to explain the large differences observed between Period 1 and Period 2. Differences in Period 1 are also illuminating and suggest individuals who gain Medicaid likely face escalating health costs that may result, through a variety of mechanisms, in enrollment in public health insurance coverage.
Our first entropy-balanced model was weighted on our baseline set of covariates, and our second model was additionally weighted based on round 1 and 2 outcome values, which eliminated Period 1 trend differences (Table S2) . Entropy-balanced estimates were substantively similar to each other and to our primary analysis, with one exception. When we weighted on round 1 and 2 outcomes, our difference-in-differences estimates for increases in ED visits and inpatient visits became statistically significant, and the decrease in out-of-pocket spending, while similar in magnitude, was no longer statistically significant.
We also re-estimated cost models using a two-part model. We found smaller, though still statistically significant, increases in total costs and total prescription drug costs, as well as significant reductions in both total out-of-pocket costs and out-of-pocket prescription drug costs (Table S3) ; these results did not substantively alter our main findings.
In a final sensitivity analysis, we varied the definitions for both study groups. For those gaining Medicaid, we varied the length of uninsured months and time enrolled in Medicaid; for those remaining uninsured, we varied the requirements for the months remaining uninsured. Results were similar to estimates from our primary model specification (Table S4 ).
| D ISCUSS I ON
Among a national sample of previously uninsured Americans, enrollment in Medicaid was associated with significant increases in total medical spending and reductions in out-of-pocket costs, higher levels of prescription medication use, and improvements in access to care relative to individuals who remained uninsured. Those who gained Medicaid also had meaningful improvements in serious TA B L E 4 Changes in health care costs, utilization, access, and outcomes among nonelderly uninsured adults who gained Medicaid psychological distress. These findings suggest Medicaid has economically and clinically important effects on outcomes that matter to both patients and policymakers. we were unable to fully adjust for these possibilities, we employed entropy balancing in our sensitivity analyses as an additional type of control. Estimates of costs, prescription drug utilization, and access to care from our entropy balancing models were substantively similar to our primary specification.
A second limitation is that only 1 year of data was available after the ACA-sponsored Medicaid expansion occurred in some states (i.e, 2014), and therefore, we could not determine whether gaining Medicaid coverage under the ACA had differential effects compared to gaining Medicaid in prior years. A final limitation is that the access to care outcomes refers to the preceding 12 months. While these measures were generally obtained toward the end of each MEPS data period (i.e, quarter 3 or 4), some responses might refer to previous periods of insurance and bias estimates toward the null. However, we are unaware of other contemporary datasets that could be used to track uninsured populations into Medicaid coverage to examine the outcomes presented in this study at the national level.
| CON CLUS ION
Twenty-eight million Americans remain uninsured in the United
States, 41 and this number is expected to rise following the recent repeal of tax penalties related to the individual mandate and other federal changes to Medicaid eligibility. 42, 43 Our study suggests 
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